Exchange: NASDAQ·Updated 04:35 PM EDT
AQST logo

AQST Aquestive Therapeutics Inc

$5.25
$0.03
(0.56%)
Today
Closed $5.35
$0.0993
(1.86%)
After Hours
Reported EarningsAug 11
Mkt Cap$675.25M
Vol1.83M

About AQST

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
39

Bearish Sentiment

How do you feel about AQST?

Advertisement|Remove ads.